Literature DB >> 29774587

Intravenous immunoglobulins in dermatology. Part 2: clinical indications and outcomes.

E Forbat1, F R Ali2, F Al-Niaimi2.   

Abstract

Intravenous immunoglobulin (IVIg) is a solution of human IgG, salt, sugars and solvents used to treat a multitude of diseases. Although IVIg has been known to treat many diseases safely and successfully, there are relatively few supporting randomized controlled trials. In part two of this review, we assess the clinical indications of IVIg in dermatological disorders and the outcomes of its use.
© 2018 British Association of Dermatologists.

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29774587     DOI： 10.1111/ced.13552

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN： 0307-6938            Impact factor:   3.470


  4 in total

1.  Low-dose subcutaneous immunoglobulin is an effective treatment for autoimmune bullous skin disorders: A case report.

Authors:  Erin Streu; Marni C Wiseman; James B Johnston
Journal:  SAGE Open Med Case Rep       Date:  2020-01-21

Review 2.  Pemphigus Vulgaris: Present and Future Therapeutic Strategies.

Authors:  Dario Didona; Giovanni Paolino; Giovanni Di Zenzo; Biagio Didona; Riccardo Pampena; Matteo Riccardo Di Nicola; Santo Raffaele Mercuri
Journal:  Dermatol Pract Concept       Date:  2022-01-01

3.  Response to low-dose intravenous immunoglobulin in a case of recalcitrant Darier disease.

Authors:  Adeline Legrand; Anne-Sophie Darrigade; Alain Taieb; Brigitte Milpied; Julien Seneschal
Journal:  JAAD Case Rep       Date:  2020-02-19

Review 4.  Immune-Mediated Dermatoses in Patients with Haematological Malignancies: A Comprehensive Review.

Authors:  Roberto Maglie; Giovanni Genovese; Farzan Solimani; Alba Guglielmo; Alessandro Pileri; Francesca Portelli; Michael Hertl; Angelo Valerio Marzano; Emiliano Antiga
Journal:  Am J Clin Dermatol       Date:  2020-12       Impact factor: 7.403
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.